Corporation
Management
BDV, Expanding into the Chinese Offline Market Following Online Success
SHINSEGAE INTERNATIONAL’s in-house cosmetics brand, VIDIVICI, is set to expand its reach into offline channels by leveraging the strong foothold it has established in the Chinese online market. The br…
- 2026-07-30 08:56:59
- KYUNG GYEYOUNG
Lifestyle
"New Lotte Speed"... LotteChilsungBeverage Calls All Employees "Pros"
LotteChilsungBeverage is shifting to a role- and performance-based personnel system by introducing “GL” (Growth Level), the Lotte Group’s new personnel system. The plan is to unify all employees under…
- 2026-07-30 08:47:20
- kim mi-kyung
Electronics
Huge Bonuses Don’t Come for Free… SK Hanik’s Unprecedented Hiring Drive Causes a Stir
SK hynix is overhauling its recruitment process to select new hires based on their ability to utilize artificial intelligence (AI) and their critical thinking skills in identifying the root causes of …
- 2026-07-30 08:31:40
- JAEMIN SONG
Lifestyle
Cellbion Co., Ltd Begins Clinical Trial Combining Keytruda with Merck... Company Valuation Set to Rise
#Cellbion Co., Ltd, a company specializing in radiopharmaceuticals (RPT), is expected to see its corporate value reassessed as it moves to commercialize a prostate cancer treatment and enhance the val…
- 2026-07-30 08:31:02
- YU JIN-HEE
Lifestyle
Investors Ask... What Is the Post-IPO Growth Roadmap and What Are the Risk Factors? [In-Depth Look at Ingenia ③]
Ingenia Therapeutics is set to receive milestone payments totaling 50 billion won from Merck by the end of this year. In addition, Edaily’s premium pharma and biotech content platform, PharmEdaily, ha…
- 2026-07-30 08:11:04
- YU JIN-HEE
Lifestyle
The Key Technology Merck Has Set Its Sights On... Targeting a $5 Billion Market Value [In-Depth Look at Ingenia, Part 2]
The driving force behind global pharmaceutical and biotech companies’ large-scale investment in Ingenia Therapeutics’ technology lies in “LCIDEC” (Ligand Capture, Internalization, Degradation in EC), …
- 2026-07-30 08:11:03
- YU JIN-HEE
Lifestyle
U.S.-Based Biotech Company Sets to Become a Successful KOSDAQ Listing [In-Depth Look at Ingenia, Part 1]
Ingenia Therapeutics (Ingenia), an innovative antibody drug development company headquartered in Boston, U.S., has passed the Korea Exchange’s preliminary review for a KOSDAQ listing and is now moving…
- 2026-07-30 08:11:02
- YU JIN-HEE
Lifestyle
Choi Seok-geun, CEO of EyeGene,Inc: “The Nation’s Only Combination of mRNA and GCT Technologies Will Accelerate the Path to a ‘Profitable Biotech Company’”
"We will break free from the limitations of a biotech venture that remains confined to research and development (R&D). By progressively commercializing our proven revenue-generating pipeline—including…
- 2026-07-30 08:01:02
- YU JIN-HEE
Lifestyle
Patient Monitoring Market: A Silent Battle... SEERS’ Strategy to Expand into Neurology
As competition in the domestic patient monitoring market intensifies, SEERS TECHNOLOGY(458870)is seeking to differentiate itself by expanding its market presence based on clinical data. Rather than en…
- 2026-07-30 07:31:02
- SONG YOUNG-DOO
Electronics
"People Still Line Up Even When Prices Rise"... MLCC Industry Smiles
As the shortage of multilayer ceramic capacitors (MLCCs) for artificial intelligence (AI) servers worsens, major manufacturers are beginning to raise prices in earnest. SamsungElectroMechanics has dec…
- 2026-07-30 04:00:07
- JAEMIN SONG
PHARM EDAILY
Shorts